2 terminated. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 3 | 2 | Terminated 2 |
Follow Motion Sickness: new trials by email Literature Review of Motion Sickness trials Research Report on Motion Sickness
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness DPI-386 Nasal Gel, DPI-386 Placebo Nasal Gel, Transderm Scop® - Motion Sickness | Phase 2 / Phase 3 | Terminated | Repurposed Therapeutics, Inc. | 23 | 2018-06-29 | 2020-01-07 |
| Pharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray Scopolamine, Placebo - Motion Sickness | Phase 2 / Phase 3 | Terminated | Repurposed Therapeutics, Inc. | 63 | 2014-06-01 | 2018-01-17 |
Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2)
Scopolamine (2)
Repurposed Therapeutics, Inc. (2)
United States (2)
David Helton (1) · Willliam J Becker, Phd (1)